Morgan Stanley Maintains Equal-Weight on Haemonetics, Raises Price Target to $88

Morgan Stanley analyst Drew Ranieri maintains Haemonetics (NYSE:HAE) with a Equal-Weight and raises the price target from $84 to $88.

Morgan Stanley analyst Drew Ranieri maintains Haemonetics (NYSE:HAE) with a Equal-Weight and raises the price target from $84 to $88.

Total
0
Shares
Related Posts